Heart Disease Trial, Recruiting NCT06092437 Sponsor: Zuyderland Medisch Centrum Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06092437
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have been diagnosed with heart failure (any type — where the heart pumps weakly, moderately weakly, or with a stiff heart muscle), diagnosed using recognised European heart failure guidelines
  • People who are currently experiencing an episode of worsening heart failure, shown by having at least one symptom (such as breathlessness, difficulty breathing when lying flat, or swelling) AND at least one physical sign (such as crackling sounds in the lungs, swelling in the legs, fluid in the abdomen, or signs of fluid in the lungs on a chest X-ray)
  • People whose blood test shows an elevated NT-proBNP level above 300 pg/ml (a marker that indicates heart stress)
  • People who need diuretics ("water tablets") given through a drip (intravenously)

Who may not be able to join:

  • People with very severe kidney failure — specifically those on dialysis or whose kidney function measurement (eGFR) is below 10 mL/min/1.73 m² (confirm with trial site)
  • People who are already taking part in another research study related to heart failure
  • People who are admitted in a critical condition, such as those experiencing cardiogenic shock (when the heart suddenly cannot pump enough blood), serious breathing failure, or any other condition requiring immediate intensive care unit admission (note: being transferred to intensive care later during the hospital stay does not appear to be an exclusion)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 088 - 459 9701

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zuyderland Medisch Centrum
Registry
ClinicalTrials.gov
Start date
27 February 2023
Est. completion
27 June 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Hierarchical composite of all-cause mortality, heart failure events and delta quality of life at 90 days follow-up.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov